echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > JEADV: Study on the improvement of hair loss in patients with psoriasis treated with risankizumab

    JEADV: Study on the improvement of hair loss in patients with psoriasis treated with risankizumab

    • Last Update: 2022-04-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com




    Figure 1.


     

    Figure 2.


    The literature has described the efficacy of JAK inhibitors such as tofacitinib for psoriasis and alopecia areata; however, it is for psoriatic arthritis, not psoriasis


    Source: Martora F, Villani A, Ocampo-Garza SS, Alopecia universalis improvement following risankizumab in a psoriasis patient Running head, J Eur Acad Dermatol Venereol 2022 Feb 19; 



    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.